Home

Content about urology

03.18.10
Association Of Interleukin-18 Gene Polymorphisms With Calcium Oxalate Kidney Stone Disease

UroToday.com - In the past few years, we have been working to explore the possible gene single nucleotide polymorphisms (SNPs) as genetic makers for renal stone diseases. Calcium oxalate urolithiasis is a multi-factorial disease. The majority are idiopathic, indicating the absence of any identifiable clinical cause of the disease...

03.18.10
Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer

UroToday.com - In this study, we reported our experience with sacral insufficiency fractures (IF) in patients with prostate cancer who underwent pelvic radiotherapy as part of their definitive treatment. Insufficiency fractures are considered a rare complication of radiotherapy. IF has been described after irradiation for gynaecologic, anal, and rectal cancer...

03.18.10
Laparoscopic Radical Nephrectomy For Renal Cell Carcinoma: Oncological Outcomes At 10 Years Or More

UroToday.com - Key finding: Perioperative and surrogate oncologic outcomes were analyzed in the urological literature. In this study, however, we were able to address the remaining concern of long-term oncological outcomes after laparoscopic radical nephrectomy. In 73 patients with kidney cancer undergoing laparoscopic radical nephrectomy and followed for mean 11...

03.17.10
Do Weather Conditions Influence The Onset Of Renal Colic? A Novel Approach To Analysis

UroToday.com - In our study we demonstrated an association between the onset of renal colic and exposure to hot and dry weather, particularly when temperatures rose above 27° C and relative humidity fell below 45%. A clear evidence on this issue is still lacking in the specific literature, despite a number of papers recently published on this topic [1]...

03.17.10
Fesoterodine For The Treatment Of Urinary Incontinence And Overactive Bladder

UroToday.com - The first placebo-controlled superiority trial between 2 antimuscarinic agents was recently performed comparing fesoterodine 8mg to tolterodine ER 4mg and placebo. The study was a 12 week randomized, double-blind, double-dummy, placebo-controlled trial in patients with OAB and at least 1 urgency urinary incontinence (UUI) episode per 24 hours on a 3 day diary at baseline...

03.17.10
Minorities At Greater Risk For Kidney Disease

Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD) , which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation (NKF)...

03.17.10
Pelvic Pain And Surgeries In Women Before Interstitial Cystitis/Painful Bladder Syndrome - Chronic Pelvic Pain, BPS And Pelvic Surgical Procedures

UroToday.com - For years, bladder pain syndrome series have reported apparently high numbers of BPS patients with a history of hysterectomy and other pelvic surgeries. No study has compared cases with controls prior to onset of BPS symptoms...

03.17.10
Risk Factor Analysis In A Contemporary Cystectomy Cohort Using Standardized Reporting Methodology And Adverse Event Criteria

UroToday.com - Despite significant improvements in surgical technique, preoperative preparation and perioperative care since the inception of radical cystectomy (RC), the complication rate associated with this operation remains high. Patients requiring RC are elderly with considerable associated comorbidities due to the strong association of cigarette smoking and urothelial bladder carcinoma...

03.17.10
Urologic Nurses Named Continence Care Champion

The National Association For Continence (NAFC) awarded Leslie Saltzstein Wooldridge, MSN, RNCS, GNP-BC, and Francie Bernier, PhD, MSN, RNC with the Rodney Appell Continence Care Champion Award at the Society of Urologic Nurses and Associates (SUNA) Annual Symposium on March 12, 2010...

03.16.10
A Randomized Trial Of Photoselective Vaporization Of The Prostate Using The 80-W Potassium-titanyl-phosphate Laser Vs. Transurethral Prostatectomy

UroToday.com - The treatment of lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction (BOO) makes up a significant amount of the workload of most urologists...

03.16.10
Benign Prostatic Hyperplasia: Symptoms, Symptom Scores, And Outcome Measures

UroToday.com - Our chapter on BPH in the recent Urologic Clinics of North America focuses on improved methods for defining the etiology of lower urinary tract symptoms (LUTS)...

03.16.10
Costs Of Adverse Events In First-Line Metastatic Renal Cell Carcinoma Treatment: Bevacizumab In Combination With Interferon-a2a Vs Sunitinib

UroToday.com - The availability of novel and promising targeted therapies for the treatment of patients with metastatic renal cell carcinoma (RCC), such as bevacizumab plus interferon and sunitinib, has meant important increases in options for patients and physicians treating this deadly disease. It has also meant that patients can take medications, non-curatively, for long periods of time...

03.16.10
Do We Need New Surgical Techniques To Repair Vesico-Vaginal Fistulas?

UroToday.com - Vesicovaginal fistula has been a medical and social problem and remains a surgical challenge, especially when it requires re-operation, presents large size, involves the ureter and is associated with radiotherapy. In this paper, we describe our experience with complex urogenital fistulas...

03.15.10
What Is Kidney Infection? What Causes Kidney Infection?

Kidney infection, also known as pyelonephritis, is a type of urinary tract infection (UTI) typically caused by E. coli bacteria. The bacteria may have spread from the bladder or the urethra to one of the kidneys, infecting it. The urethra is a tube which transports urine from the bladder outside the body...

03.12.10
Affymax(R) Receives $5 Million Milestone Payment On Initiation Of Phase 3 Clinical Trials For Hematide™ In Japan

Affymax, Inc. (Nasdaq: AFFY) today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients...

03.12.10
Athena Feminine Technologies, Inc. Initiates Enrollment Of Phase Iv Clinical Trial For Athena Pelvic Muscle Trainer™

Athena Feminine Technologies, Inc., in partnership with the National Association of Nurse Practitioners in Women's Health, announced the initiation of a nationwide enrollment for Phase IV of the DUETS (Device for Urinary Incontinence, Effectiveness, Tolerability and Satisfaction) research study for its Athena Pelvic Muscle Trainer™ (PMT)...

03.12.10
Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options

As the incidence of diabetes and hypertension continues to grow worldwide - and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems - the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical...

03.11.10
Donating Kidney Does Not Appear To Significantly Increase Long-Term Risk Of Death

An analysis of outcomes for live kidney donors in the U.S. over a 15 year period finds they have similar long-term survival rates compared to healthy individuals who were not kidney donors, according to a study in the March 10 issue of JAMA...

03.11.10
Gastric Bypass Surgery Increases Risk Of Kidney Stones

Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests...

03.11.10
Kidney Disease A Big Risk For Younger, Low-Income Minorities

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites...